Xeris Pharmaceutical

https://www.xerispharma.com/
https://www.xerispharma.com/api/files/697

Gvoke HypoPen? / Gvoke PFS?                 FDA decision       9.10.19

Der PDUFA Termin wurde um 3 Mon auf den 9.10.19 verschoben!
https://seekingalpha.com/article/4246895-xeris-looking-entry-pdufa

Xeris Submits Glucagon Rescue Pen to FDA: A Dramatically Easier and Faster Treatment for Severe Hypoglycemia
https://diatribe.org/...sier-and-faster-treatment-severe-hypoglycemia


Glucagon Pen - EU                                         Ph 3 Results        1H ?19
Self-Administered Glucagon                      Ph 2 (Vial/Syringe)    2H ?19
Continuous Glucagon                                     Initiate Ph 3          2H ?19
Continuous Glucagon                      Ph 2 Treatment Results       2H ?19
Self-Administered Glucagon             Ph 2 in-clinic data                2H?19
Diazepam                                                 Initiate Ph 2                 2H ?19
Pramlintide-Insulin                                     Initiate Ph 2                2H ?19

Pipeline:    https://www.xerispharma.com/research-development/pipeline


As of April 30, 2019, the registrant had 26,940,229 shares of common stock outstanding

Cash and cash equivalents    $   61,984
Short-term investments         $    85,687
MK ca 328 Mio$  

https://xerispharma.gcs-web.com/news-releases/...val-gvoketm-glucagon  

https://xerispharma.gcs-web.com/news-releases/...nded-85-million-debt